USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT

摘要

A method and pharmaceutical composition for inhibiting the effect of glucocorticoids, particularly dexamethasone, which suppress growth hormone secretion, by administering ghrelin or a ghrelin analogue, specifically [Aib2, Glu3(NH-hexyl)]hGhrelin(1-28)-NH2, to counteract the catabolic effects of said dexamethasone and other natural glucocorticoids.